Journal
VIRUS RESEARCH
Volume 155, Issue 2, Pages 381-388Publisher
ELSEVIER
DOI: 10.1016/j.virusres.2010.11.006
Keywords
TMEV; L* protein; Mitochondria
Categories
Funding
- Ministry of Health, Labour and Welfare of Japan
- Ministry of Education, Culture, Sports, Science and Technology, Japan [22590421]
- Kanazawa Medical University [S2009-4, K2010-16]
- Grants-in-Aid for Scientific Research [22590421] Funding Source: KAKEN
Ask authors/readers for more resources
L* protein of TMEV is out-of-frame with the viral polyprotein from an alternative initiation codon AUG, 13 nucleotides downstream from the authentic polyprotein AUG. Anti-apoptotic activity of L* was demonstrated by both 'loss of function' and 'gain of function' experiments. However, the precise mechanism(s) of anti-apoptotic activity of L* remains to be clarified. In this study, L* was demonstrated to be localized to mitochondria. It was also shown by the GFP fusion protein that N-terminal sequence of L* may contain a mitochondrial targeting signal (MTS). Surprisingly, L(5-70)*-GFP and L(41-70)*-GFP were localized to mitochondria although L(1-70)*-GFP was distributed in the cytosol, suggesting L* has an MTS between amino acid (AA) positions 41 and 70, and that L(1-4)* inhibits its mitochondrial targeting. Furthermore, L(1-70)*-GFP was localized to the mitochondria by co-expression of L(65-156)*, indicating that L(65-156)* suppresses the inhibition of mitochondrial targeting by L(1-4)*. These results suggest that the intra- or inter-molecular interaction of L* regulates its mitochondrial localization. It is also suggested that L* may inhibit the intrinsic apoptosis through the localization to mitochondria. (C) 2010 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available